OSAKA -- Japanese researchers report taking their first steps toward possible stem-cell-based treatments for muscular dystrophy.
A Kyoto University team and chemical company Asahi Kasei created skeletal muscle stem cells from induced pluripotent stem cells, or iPS cells. These were injected into a leg of a mouse with muscular dystrophy. In the muscle there, researchers detected a protein that kept muscle mass from deteriorating.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.